Literature DB >> 2461370

Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties.

P Waring1, R D Eichner, A Müllbacher, A Sjaarda.   

Abstract

We have previously shown that the fungal metabolite and immunomodulating agent gliotoxin induces apparently random double-stranded fragmentation of genomic DNA in a variety of cell types and double- and single-stranded scission in isolated plasmid DNA. The in vitro damage to plasmid DNA appears to be mediated by reactive oxygen species, but the mechanism of damage to genomic DNA is not yet known. In this paper we show that treatment of macrophages with gliotoxin and some analogues gives rise to discrete DNA fragments with molecular weight 170 +/- 30 base pairs. This pattern of DNA fragmentation has the characteristics of apoptosis, a programmed form of cell death. Three structural analogues of gliotoxin and two S-acetylated precursors capable of intracellular hydrolysis to the thiol form induce identical DNA degradation patterns. Only those compounds with the epipolythiodioxopiperazine (ETP) bridged disulfide structure or those capable of extracellular conversion to ETP compounds are equipotent with gliotoxin in their effects on macrophage phagocytosis, although all are capable of generating reactive oxygen species intracellularly. These results suggest that the effect of gliotoxin on macrophage function as assessed by adherence to plastic surfaces is unrelated to DNA damage and in addition suggests a new mechanism by which the toxin and other ETP compounds may damage cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2461370

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin production.

Authors:  Robert A Cramer; Michael P Gamcsik; Rhea M Brooking; Laura K Najvar; William R Kirkpatrick; Thomas F Patterson; Carl J Balibar; John R Graybill; John R Perfect; Soman N Abraham; William J Steinbach
Journal:  Eukaryot Cell       Date:  2006-06

2.  Detection of gliotoxin in experimental and human aspergillosis.

Authors:  Russell E Lewis; Nathan P Wiederhold; Jingduan Chi; Xiang Y Han; Krishna V Komanduri; Dimitrios P Kontoyiannis; Randall A Prince
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  The mechanism of cell death in Listeria monocytogenes-infected murine macrophages is distinct from apoptosis.

Authors:  J Barsig; S H Kaufmann
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 4.  Aspergillus fumigatus: principles of pathogenesis and host defense.

Authors:  Tobias M Hohl; Marta Feldmesser
Journal:  Eukaryot Cell       Date:  2007-09-21

Review 5.  Mechanisms of cell death.

Authors:  D J Fawthrop; A R Boobis; D S Davies
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

Review 6.  Virulence factors of medically important fungi.

Authors:  L H Hogan; B S Klein; S M Levitz
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

7.  Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells.

Authors:  A R Hauser; J N Engel
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

8.  Correlation between gliotoxin production and virulence of Aspergillus fumigatus in Galleria mellonella.

Authors:  Emer P Reeves; C G M Messina; S Doyle; K Kavanagh
Journal:  Mycopathologia       Date:  2004-07       Impact factor: 2.574

9.  Anti-apoptotic effect of nerve growth factor is lost in congenital insensitivity to pain with anhidrosis (CIPA) B lymphocytes.

Authors:  Yuya Sato; Yayoi Tsuboi; Hidemitsu Kurosawa; Kenichi Sugita; Mitsuoki Eguchi
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

10.  Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites.

Authors:  Ronen Ben-Ami; Russell E Lewis; Konstantinos Leventakos; Dimitrios P Kontoyiannis
Journal:  Blood       Date:  2009-10-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.